Clinical Trials
18 trialsNCT07583303 2026-05-13
BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation
City of Hope Medical Center
Phase 1 Not yet recruiting
NCT06177067 2026-05-04
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
St. Jude Children's Research Hospital
Phase 1 Recruiting
NCT06458244 2026-04-16
The Efficacy of Allo-HSCT in ND HR-CBF-AML
Ruijin Hospital
Recruiting
NCT06458257 2025-07-29
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
Ruijin Hospital
Recruiting
NCT07069933 2025-07-17
Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?
Mansoura University
Phase 2 Not yet recruiting
NCT02936089 2023-08-08
Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+
Nanfang Hospital, Southern Medical University
Phase NA Completed
NCT04764513 2022-03-28
Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT02298166 2021-10-06
Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations
University of Ulm
Phase 3 Terminated
NCT02229266 2021-08-16
HINKL
Technische Universität Dresden
Phase 2 Terminated
NCT01807091 2021-03-05
Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
University of Washington
Phase NA Completed
NCT01872819 2018-07-11
Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay
University of Washington
Phase NA Completed
NCT03453255 2018-03-05
DCHA as Postremission Therapy for AML With t(8;21)
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT00145626 2017-06-19
HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies
St. Jude Children's Research Hospital
Phase 2 Completed
NCT00640796 2014-04-24
Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
St. Jude Children's Research Hospital
Phase 1 Completed
NCT00428558 2013-12-20
Timed-Sequential Induction in CBF-AML
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT00390715 2010-03-15
Treatment of Acute Myeloblastic Leukemia in Younger Patients
PETHEMA Foundation
Completed
NCT00931138 2009-07-02
ALFA 9801
Acute Leukemia French Association
Phase 3 Completed
NCT00152139 2009-01-29
Stem Cell Transplantation for Patients With Hematologic Malignancies
St. Jude Children's Research Hospital
Phase 3 Completed